On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Micron MU, adding that he likes the company and its CEO Sanjay Mehrotra.
On May 6, Baird analyst Tristan Gerra upgraded Micron from Neutral to Outperform and raised the price target from $115 to $150.
Bank of America Corporation BAC is a buy, Cramer said.
Earlier this month, Bank of America recommended shareholders reject “mini-tender” offer by Tutanota LLC.
When asked about JFrog Ltd. FROG, he said, “I would be a seller of almost all the enterprise software companies here.”
On May 9, JFrog posted stronger-than-expected results for its first quarter. The company also said it sees FY24 adjusted earnings of 59 cents to 61 cents per share, on revenue of $425.5 million to $429.5 million.
The “Mad Money” host said he is not impressed with what Biogen BIIB is doing.
On April 24, Biogen reported first-quarter adjusted EPS of $3.67, up 8%, beating the consensus of $3.44.
Cramer said Fidelis Insurance Holdings Limited FIHL is “not a favorite.”
On May 9, Fidelis Insurance posted better-than-expected earnings for its first quarter.
Chevron Corporation CVX is a buy, he said.
On May 10, Truist Securities analyst Neal Dingmann maintained Chevron with a Hold and raised the price target from $156 to $166.
Price Action:
- Biogen shares fell 0.6% to settle at $221.50 on Friday.
- Micron shares fell 4.8% to close at $6.09.
- Bank of America shares gained 0.4% to settle at $38.45.
- Fidelis Insurance shares fell 4.3% to close at $18.48 on Friday.
- JFrog shares dipped 18.7% to settle at $33.01 on Friday.
- Chevron shares gained 0.2% to close at $165.82.
Read Next: Top 3 Industrials Stocks That May Collapse This Month
Image: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
